National Institutes of Health Donates Protease Inhibitor Patent to UNITAID Medicines Patent Pool
On September 30, 2010 the U.S. National Institutes of Health (NIH) became the first research funder to license intellectual property rights to the Medicines Patent Pool essential to manufacturing anti-HIV protease inhibitors. The patent pool is an innovative initiative that -- by pooling patents from diverse inventors -- will allow the manufacture of low-cost, high-quality generic medications for people with HIV and other life-threatening diseases in low- and middle-income countries.
By becoming the first research funder to license medical patents to the Medicines Patent Pool, the NIH has taken a historic step toward facilitating equitable global access to medical innovations created with taxpayer funds to fight such diseases of global concern as HIV,View Full Article
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)